LakeShore Biopharma (LSB) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
LakeShore Biopharma Co., Ltd has announced the resignation of Chunyuan Wu, the company’s CFO, and Zengjun Xu, a board member, both effective June 14, 2024, due to personal reasons and not because of any disputes regarding company operations. In the interim, board director Rachel Yu will step in as CFO while the company seeks a permanent replacement. The board now consists of six remaining members following these departures.
For further insights into LSB stock, check out TipRanks’ Stock Analysis page.